DEPOSIT AGREEMENTDeposit Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations • Vermont
DEPOSIT AGREEMENT, dated as of [DATE], 2014, by and among (i) Innocoll AG, a company organized under the laws of the Federal Republic of Germany, and its successors (the “Company”), (ii) CITIBANK, N.A., a national banking association organized under the laws of the United States of America acting in its capacity as depositary, and any successor depositary hereunder (the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations • New York
This EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into effective as of April 3, 2013 (the “Effective Date”) by and between INNOCOLL Pharmaceuticals Limited, an Irish corporation (collectively with its Affiliates) (“INNOCOLL”), whose principal office is at Athlone Business & Technology Park, Garrycastle, Athlone, Co. Westmeath Ireland, and Biomet 3i, LLC, (“BIOMET”), a limited liability company whose principal office is at 4555 Riverside Drive, Palm Beach Gardens, Florida 33410.
LICENSING, MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations
This Licensing, Manufacturing and Supply Agreement (the “Agreement”) is being entered into as of the 12th day of October 2011 (the “Effective Date”), by and between INNOCOLL PHARMACEUTICALS, LIMITED, an Irish Corporation (collectively, with its Affiliates “Innocoll”) whose principal office is Midlands Innovation and Research Centre, Dublin Road, Athlone, Co. Westmeath, Ireland (or “Innocoll”) and Pioneer Pharma Co. Ltd., offices located at Suite A-C 18F, HuDong Finance Building, No. 1128, Xiang Yin Road, Shanghai, China (“PIONEER”)
Amended and Restated Manufacture and Supply AgreementManufacture and Supply Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations • Pennsylvania
Confidential Materials omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment under Rule 406 under the Securities Act of 1933, as amended. Confidential portions are marked: [ *** ]
INNOCOLL AG SOFINNOVA VENTURE PARTNERS VIII, L.P. CERTAIN SHAREHOLDERS OF INNOCOLL AG SUPERVISORY BOARD MEMBER NOMINATION AND VOTING AGREEMENT DATED JULY [●], 2014Ag • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations • New York
LICENSING, MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations • Dublin
This Licensing, Manufacturing and Supply Agreement (the “Agreement”) is being entered into as of the 5th day of December 2011 (the “Effective Date”), by and between INNOCOLL PHARMACEUTICALS, LIMITED, an Irish Corporation (collectively, within its Affiliates “Innocoll”) whose principal office is Midlands Innovation and Research Centre, Dublin Road, Athlone, Co. Westmeath, Ireland (or “Innocoll”) and Saudi Centre for Pharmaceuticals, offices located at 341 Olaya Street, Riyadh, Saudi Arabia (“SCP”)
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations
This Manufacturing and Supply Agreement (the “Agreement”) is being entered into as of the first day of June 2004 (the “Effective Date”), by and between BIOMET ORTHOPAEDICS SWITZERLAND GmbH, a Swiss company organized and existing under Swiss law, with offices located at Altes Widalmi 12CH-3216 Ried bei Kerzers, Switzerland (hereinafter called “Biomet”) and Innocoll Technologies Limited, an Irish company organized and existing under Irish law, with offices located at IDA Roscommon Business and Technology Park, Gallowstown, Co. Roscommon (“Supplier” or “Innocoll”).
